Literature DB >> 21243388

Demographic, clinical, and serological features of Turkish patients with rheumatoid arthritis: evaluation of 165 patients.

Senol Kobak1.   

Abstract

The study was designed to describe demographic, clinical, serological, and radiological characteristics of patients with rheumatoid arthritis (RA) followed-up by a single institution. One hundred sixty-five patients, diagnosed as RA using ACR classification criteria, and followed-up in the rheumatology clinic between December 2005 and January 2010, were enrolled in the study. Of the patients, 125 were female, and 40 were male. Mean age of the patients was 52.5 years, and mean duration of the disease was 10.5 years. The most frequently involved joints were the wrist (95.2%), MCP (90.9%), and the PIP (92.6%). The knee and hip joint involvement rates were 44.8% and 23.6%, respectively. Patients (50.9%) were detected to have tenosynovitis. Involvement of the elbow joint was shown in 10.9% of the patients. The most common extra-articular manifestations were sicca symptom (40.6%) and carpal tunnel syndrome (35.7%), followed by pulmonary involvement (6.6%), vasculitis (3.6%), and Raynaud's phenomenon (1.2%). Rheumatoid nodules were detected in six patients (3.6%). One patient had Felty syndrome, and another patient had secondary amyloidosis. Patients (90.3%) had positive rheumatoid factor (RF), and 124 patients had positive anti-CCP antibody (75.2%). A more severe clinical course and a higher incidence of erosion, tenosynovitis, and deformities were detected in patients with anti-CCP antibody and positive RF (p = 0.03, p = 0.04, p = 0.01, p = 0.04, respectively). The wrist was the most frequently involved joint in our patients, and the most frequently seen extra-articular manifestation was sicca symptom. Presence of RF and anti-CCP antibody was associated with more severe disease including erosive and destructive arthropathy. Extra-articular involvement and presence of accompanying diseases increase the mortality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243388     DOI: 10.1007/s10067-011-1678-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.

Authors:  Cengiz Korkmaz; Tercan Us; Timuçin Kaşifoğlu; Yurdanur Akgün
Journal:  Clin Biochem       Date:  2006-07-13       Impact factor: 3.281

2.  Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey.

Authors:  M Calgüneri; K Ureten; M Akif Oztürk; A M Onat; I Ertenli; S Kiraz; A Akdogan
Journal:  Clin Exp Rheumatol       Date:  2006 May-Jun       Impact factor: 4.473

3.  [The prevalence of rheumatoid arthritis and the rheumatoid factor in the native inhabitants of northeastern Siberia].

Authors:  Sh Erdes; L I Alekseeva; M Iu Krylov; A N Kariakin; L I Benevolenskaia
Journal:  Ter Arkh       Date:  1999       Impact factor: 0.467

4.  A comparison of the clinical features of hospital out-patients with rheumatoid disease and osteoarthritis in Pakistan and England.

Authors:  K Hameed; T Gibson
Journal:  Br J Rheumatol       Date:  1996-10

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study.

Authors:  A A Drosos; J S Lanchbury; G S Panayi; H M Moutsopoulos
Journal:  Arthritis Rheum       Date:  1992-07

7.  Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis.

Authors:  H Bodur; S Ataman; L Akbulut; D Evcik; V Kavuncu; T Kaya; R Günaydin; B Kuran; N Kotevoğlu; A Bal; E Aydoğ; Z Altay; H Uğurlu; H Kocabaş; N Olmez; P Yazgan; S Gürsoy; E Madenci; S Ozel; S U Delialioğlu
Journal:  Clin Rheumatol       Date:  2008-03-21       Impact factor: 2.980

8.  Prevalence of rheumatoid arthritis in the adult Indian population.

Authors:  A N Malaviya; S K Kapoor; R R Singh; A Kumar; I Pande
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

9.  The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

Authors:  A van der Heide; J W Jacobs; J W Bijlsma; A H Heurkens; C van Booma-Frankfort; M J van der Veen; H C Haanen; D M Hofman; G A van Albada-Kuipers; E J ter Borg; H L Brus; H J Dinant; A A Kruize; Y Schenk
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

10.  QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Sergio Toloza; Heidi Mäkinen; Suzan M M Verstappen; Merete Lund Hetland; Antonio Naranjo; Eva Baecklund; Gertraud Herborn; Rolf Rau; Massimiliano Cazzato; Laure Gossec; Vlado Skakic; Feride Gogus; Stanislaw Sierakowski; Barry Bresnihan; Peter Taylor; Catherine McClinton; Theodore Pincus
Journal:  Ann Rheum Dis       Date:  2007-04-05       Impact factor: 19.103

View more
  4 in total

Review 1.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 2.  Felty's syndrome without rheumatoid arthritis?

Authors:  Ap Rozin; R Hoffman; T Hayek; A Balbir-Gurman
Journal:  Clin Rheumatol       Date:  2013-01-05       Impact factor: 2.980

3.  Felty's Syndrome, Insights and Updates.

Authors:  Mohammad Bagher Owlia; Kam Newman; Mojtaba Akhtari
Journal:  Open Rheumatol J       Date:  2014-12-31

4.  Handheld dermatoscopy as an easy-to-use capillaroscopic instrument in rheumatoid arthritis: a cross-sectional study

Authors:  Ömer Faruk Elmas; Mehmet Okçu; Abdullah Demirbaş; Necmettin Akdeniz
Journal:  Turk J Med Sci       Date:  2020-10-22       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.